glp-1 gip therapy alternatives 2025 What is the pipeline for future medications for obesity? Free Comparison Chart: GLP-1 and
Description
(Silver Spring) 29 , 11201127 (2021)
In a recent study, Newsome et al
13 The efficacy in these studies is akin to what we have observed following treatment with exenatide for 3 months (5.6 cmCSF)
Eli Lilly Positioning: Eli Lilly is a close competitor to Novo Nordisk, with its flagship GLP-1 receptor agonist Trulicity (dulaglutide) used for type 2 diabetes
244 Conversely, the expression level of GLP-1R on -cells is relatively high
This helps you feel fuller for longer, reduces cravings, and supports sustainable weight loss
